Biomarker Development for Muscular Dystrophies
Biomarker Development for Muscular Dystrophies
Recruiting · NCT05019625 · Registry updated 2025-11-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarker Development for Muscular Dystrophies | Becker muscular dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, facioscapulohumeral muscular dystrophy, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease | Recruiting | Not stated | 2025-11-24 | NCT05019625 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston Children's Hospital | 238 |
| Brigham and Women's Hospital | 378 |
| Massachusetts General Hospital | 758 |
| University of Pittsburgh | 313 |
| Wake Forest University | 35 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Brigham and Women's Hospital | Boston | United States | 511 |
| Massachusetts General Hospital | Boston | United States | 20 |
| University of Pittsburgh | Pittsburgh | United States | 137 |
| Wake Forest University | Winston-Salem | United States | 22 |